Avion Wealth’s NeoGenomics NEO Stock Holding History

Avion Wealth’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-200	Closed	-$9K	–	408
2021 Q2	$9K	Hold	200	–	–	﹤0.01%	234
2021 Q1	$10K	Buy	+200	New	+$10.4K	﹤0.01%	217

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Avion Wealth's NEO Position: Q3 2021 in Review

Avion Wealth sold out of NeoGenomics (NEO) in Q3 2021, closing a stake of 200 shares — an estimated $9K sold.

Avion Wealth first reported a position in NEO in Q1 2021 and held it in 2 quarters. The position peaked at $10K in Q1 2021. 324 funds tracked by Wall St. Rank hold NEO as of Q3 2021.

Avion Wealth reported no remaining NeoGenomics position as of Q3 2021 after selling out during the quarter.
Avion Wealth sold 200 NeoGenomics shares in Q3 2021, an estimated $9K.
Avion Wealth first reported a position in NeoGenomics in Q1 2021 and held it in 2 quarters.
Avion Wealth's NeoGenomics position peaked at $10K in Q1 2021.
324 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2021.

Based on Avion Wealth's 13F filing for Q3 2021, filed 1 Nov 2021.